Activation of transcription factors activator protein-1 and nuclear factor-κB by 2,3,7,8-Tetrachlorodibenzo-p-dioxin

Biochemical Pharmacology

Volumn 59, Issue 8, 2000, Pages 997-1005

  Puga, Alvaro ^a   Barnes, Sonya J ^a   Chang, Ching Yi ^a   Zhu, Huan ^a   Nephew, Kenneth P ^b   Khan, Sohaib A ^b   Shertzer, Howard G ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Neurbio   (United States)

Author keywords

Ah receptor; AP 1; Dioxin; NF B; Oxidative stress; Transcription

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ETHOXYRESORUFIN DEETHYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE OVEREXPRESSION; HEPATOMA CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CARCINOGENS; CYTOCHROME P-450 CYP1A1; DNA; MICE; NF-KAPPA B; OXIDATIVE STRESS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0033969839     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00406-2     Document Type: Article

References (81)

1. Stohs S.J. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Free Radic Biol Med. 9:1990;79-90.
2. Hébert C.D., Harris M.W., Elwell M.R., Birnbaum L.S. Relative toxicity and tumor-promoting ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,4,7,8-pentachlorodibenzofuran (PCDF), and 1,2,3,4,7,8-hexachlorodibenzofuran (HCDF) in hairless mice. Toxicol Appl Pharmacol. 102:1990;362-377.
3. Whitlock J.P. Jr. Mechanistic aspects of dioxin action. Chem Res Toxicol. 6:1993;754-763.
4. Pirkle J.L., Wolfe W.H., Patterson D.G., Needham L.L., Michalek J.E., Miner J.C., Peterson M.R., Phillips D.L. Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam veterans of Operation Ranch Hand. J Toxicol Environ Health. 27:1989;165-171.
5. Pitot H.C., Goldsworthy T., Campbell H.A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 40:1980;3616-3620.
6. Toth K., Somfai-Relle S., Sugar J., Bence J. Carcinogenicity testing of herbicide 2,4,5-trichlorophenoxyethanol containing dioxin and of pure dioxin in Swiss mice. Nature. 27:1979;548-549.
7. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.N., Barnard S.D., Hummel R.A., Humiston C.G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 46:1978;279-303.
8. Liu R.M., Vasiliou V., Zhu H., Duh J.L., Tabor M.W., Puga A., Nebert D.W., Sainsbury M., Shertzer H.G. Regulation of [Ah] gene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2,-b]indole in mouse hepatoma cell lines. Carcinogenesis. 15:1994;2347-2352.
9. Nebert D.W. The Ah locus Genetic differences in toxicity, cancer, mutation, and birth defects . Crit Rev Toxicol. 20:1989;153-174.
10. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J Biol Chem. 271:1996;13422-13429.
11. Tissieres A., Georgopoulos C., Kullik I., Storz G. Transcriptional regulators of the oxidative stress response in prokaryotes and eukaryotes. Redox Report. 1:1994;23-29.
12. Staal F.J., Roederer M., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA. 87:1990;9943-9947.
13. Scheck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
14. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA. 88:1991;4328-4332.
15. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med. 175:1992;1181-1194.
16. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 270:1995;16483-16486.
17. Choi H.S., Moore D.D. Induction of c-fos and c-jun gene expression by phenolic antioxidants. Mol Endocrinol. 7:1993;1596-1602.
18. Park J.Y., Shigenaga M.K., Ames B.N. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc Natl Acad Sci USA. 19:1996;2322-2327.
19. Shertzer H.G., Nebert D.W., Puga A., Ary M., Sonntag D., Dixon K., Robinson L.J., Cianciolo E., Dalton T.P. TCDD causes a sustained oxidative stress response in C57BL/6J mice. Biochem Biophys Res Commun. 253:1998;44-48.
20. Yao Y., Hoffer A., Chang C.Y., Puga A. Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme. Environ Health Perspect. 103:1995;366-371.
21. Capdevila J., Gil L., Orellana M., Marnett L.J., Mason J.I., Yadagiri P., Falck J.R. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys. 261:1988;257-263.
22. Capdevila J., Falck J.R., Estabrook R.W. Cytochrome P450 and the arachidonate cascade. FASEB J. 6:1992;731-736.
23. Rifkind A.B., Gannon M., Gross S.S. Arachidonic acid metabolism by dioxin-induced cytochrome P-450 A new hypothesis on the role of P-450 in dioxin toxicity . Biochem Biophys Res Commun. 172:1990;1180-1188.
24. Nakai K., Ward A.M., Gannon M., Rifkind A.B. β-Naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. J Biol Chem. 267:1992;19503-19512.
25. Lee C.A., Lawrence B.P., Kerkvliet N.I., Rifkind A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes Evidence for species-specific differences in responses . Toxicol Appl Pharmacol. 153:1998;1-11.
26. Puga A., Bohm J., Hoffer A., Leikauf G.D., Shertzer H.G., Zhou S. Dioxin alters calcium homeostasis and the regulation of arachidonate metabolism in mouse hepatoma cells. Proc 15th Int Symp Chlor Dioxins. 25:1995;381-386.
27. Puga A., Hoffer A., Zhou S., Bohm J.M., Leikauf G.D., Shertzer H.G. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol. 54:1997;1287-1296.
28. Kraemer S.A., Arthur K.A., Denison M.S., Smith W.L., DeWitt D.L. Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin. Arch Biochem Biophys. 330:1996;319-328.
29. Puga A., Nebert D.W., Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11:1992;269-281.
30. Hoffer A., Chang C.Y., Puga A. Dioxin induces fos and jun gene expression by Ah receptor dependent- and independent-pathways. Toxicol Appl Pharmacol. 141:1996;238-247.
31. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB An oxidative stress-responsive transcription factor of eukaryotic cells (a review) . Free Radic Res Commun. 17:1992;221-237.
32. Krejsa C.M., Nadler S.G., Esselstyn J.M., Kavanagh T.J., Ledbetter J.A., Schieven G.L. Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB. J Biol Chem. 272:1997;11541-11549.
33. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., Bours V. Multiple redox regulation in NF-κB transcription factor activation. Biol Chem. 378:1997;1237-1245.
34. Bernard H.P., Darlington G.J., Ruddle F.H. Expression of liver phenotypes in cultured mouse hepatoma cells Synthesis and secretion of serum albumin . Dev Biol. 35:1973;83-96.
35. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol. 35:1995;307-340.
36. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
37. Carrier F., Owens R.A., Nebert D.W., Puga A. Dioxin-dependent activation of murine Cyp1a-1 transcription requires protein kinase C-dependent phosphorylation. Mol Cell Biol. 12:1992;1856-1863.
38. Kerkvliet N.I. Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 103:(Suppl 9):1995;47-53.
39. Yamaguchi K., Matulka R.A., Shneider A.M., Toselli P., Trombino A.F., Yang S., Hafer L.J., Mann K.K., Tao X.J., Tilly J.L., Near R.I., Sherr D.H. Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. Toxicol Appl Pharmacol. 147:1997;190-203.
40. Morris D.L., Jeong H.G., Jordan S.D., Kaminski N.E., Holsapple M.P. Characterization of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin B6C3F1 and DBA/2 mice following single and repeated exposures. Arch Toxicol. 72:1998;157-168.
41. Sulentic C.E., Holsapple M.P., Kaminski N.E. Aryl hydrocarbon receptor-dependent suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol. 53:1998;623-629.
42. Abbott B.D., Perdew G.H., Birnbaum L.S. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol Appl Pharmacol. 126:1994;16-25.
43. Birnbaum L.S. The mechanism of dioxin toxicity Relationship to risk assessment . Environ Health Perspect. 102:(Suppl 9):1994;157-167.
44. Birnbaum L.S. Developmental effects of dioxins. Environ Health Perspect. 103:(Suppl 7):1995;89-94.
45. Imagawa M., Chiu R., Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways Protein kinase C and cAMP . Cell. 51:1987;251-260.
46. Kemler I., Schreiber E., Müller M.M., Matthias P., Schaffner W. Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter. EMBO J. 8:1989;2001-2008.
47. Kemler I., Schaffner W. Octamer transcription factors and the cell type-specificity of immunoglobulin gene expression. FASEB J. 4:1990;1444-1449.
48. Liou H.C., Baltimore D. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol. 5:1993;477-487.
49. Wanner R., Zhang J., Henz B.M., Rosenbach T. AP-2 gene expression and modulation by retinoic acid during keratinocyte differentiation. Biochem Biophys Res Commun. 223:1996;666-669.
50. Pollenz R.S. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and non-hepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol. 49:1996;391-398.
51. Roman B.L., Pollenz R.S., Peterson R.E. Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation . Toxicol Appl Pharmacol. 150:1998;228-239.
52. Chang C.Y., Puga A. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol. 18:1998;525-535.
53. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
54. Cantrell S.M., Lutz L.H., Tillitt D.E., Hannink M. Embryotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) The embryonic vasculature is a physiological target for TCDD-induced DNA damage and apoptotic cell death in Medaka (Orizias latipes) . Toxicol Appl Pharmacol. 141:1996;23-34.
55. Cantrell S.M., Joy-Schlezinger J., Stegeman J.J., Tillitt D.E., Hannink M. Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced apoptotic cell death in the embryonic vasculature with embryotoxicity. Toxicol Appl Pharmacol. 148:1998;24-34.
56. Xanthoudakis S., Miao G.G., Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci USA. 91:1994;23-27.
57. Beebe L., Park S.S., Anderson L.M. Differential enzyme induction of mouse liver and lung following a single low or high dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Biochem Toxicol. 5:1990;211-219.
58. Puga A., Hoffer A., Zhou S., Bohm J.M., Leikauf G.D., Shertzer H.G. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse. Biochem Pharmacol. 54:1997;1287-1296.
59. Ortiz de Montellano P.R., Chan W.K., Tuck S.F., Kaikaus R.M., Bass N.M., Peterson J.A. Mechanism-based probes of the topology and function of fatty acid hydroxylases. FASEB J. 6:1992;695-699.
60. Olnes M.J., Verma M., Kurl R.N. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated gene expression in the immature rat thymus. Exp Clin Immunogenet. 11:1994;102-109.
61. Kang S.M., Tran A.C., Grilli M., Lenardo M.J. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science. 256:1992;1452-1456.
62. Franzoso G., Bours V., Park S., Tomita-Yamaguchi M., Kelly K., Siebenlist U. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature. 359:1992;339-342.
63. Tian Y., Ke S., Denison M.S., Rabson A.B., Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem. 274:1999;510-515.
64. Grilli M., Goffi F., Memo M., Spano P.F. Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem. 271:1996;15002-15007.
65. Grilli M., Memo M. Nuclear factor-κB/Rel proteins A point of convergence of signaling pathways relevant in neuronal function and dysfunction . Biochem Pharmacol. 57:1998;1-7.
66. Curran T., Franza B.R. Jr. Fos and Jun the AP-1 connection . Cell. 55:1988;395-397.
67. Cohen D.R., Curran T. The structure and function of the fos proto-oncogene. Crit Rev Oncog. 1:1989;65-88.
68. Bravo R. Growth factor-responsive genes in fibroblasts. Cell Growth Differ. 1:1990;305-309.
69. Morgan J.I., Curran T. Proto-oncogene transcription factors and epilepsy. Trends Pharmacol Sci. 12:1991;343-349.
70. Holbrook N.J., Fornace A.J. Jr. Response to adversity Molecular control of gene activation following genotoxic stress . New Biol. 3:1991;825-833.
71. Schulze-Osthoff K., Los M., Baeuerle P.A. Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol. 50:1995;735-741.
72. Stein B., Baldwin A.S. Jr, Ballard D.W., Greene W.C., Angel P., Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:1993;3879-3891.
73. Bereta J., Cohen M.C., Bereta M. Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells Involvement of NF-kappa B . FEBS Lett. 377:1995;21-25.
74. Gille J., Swerlick R.A., Lawley T.J., Caughman S.W. Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood. 87:1996;211-217.
75. Albelda S.M., Buck C.A. Integrins and other cell adhesion molecules. FASEB J. 4:1990;2868-2880.
76. Hynes R.O. Integrins Versatility, modulation, and signaling in cell adhesion . Cell. 69:1992;11-25.
77. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 49:1987;741-752.
78. Reyes H., Reiz-Porszasz S., Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science. 256:1992;1193-1195.
79. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases . Science. 252:1991;1427-1430.
80. Borgmeyer U., Nowock J., Sippel A.E. The TGGCA-binding protein A eukaryotic nuclear protein recognizing a symmetrical sequence on double-stranded linear DNA . Nucleic Acids Res. 12:1984;4295-4311.
81. Verrijzer C.P., Kal A.J., van der Vliet P.C. The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain. Genes Dev. 4:1990;1964-1974.